These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37972575)

  • 1. Inhibition of transforming growth factor-β signals suppresses tumor formation by regulation of tumor microenvironment networks.
    Tokizaki S; Podyma-Inoue KA; Matsumoto T; Takahashi K; Kobayashi M; Ibi H; Uchida S; Iwabuchi S; Harada H; Hashimoto S; Miyazono K; Shirouzu M; Watabe T
    Cancer Sci; 2024 Jan; 115(1):211-226. PubMed ID: 37972575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting all transforming growth factor-β isoforms with an Fc chimeric receptor impairs tumor growth and angiogenesis of oral squamous cell cancer.
    Takahashi K; Akatsu Y; Podyma-Inoue KA; Matsumoto T; Takahashi H; Yoshimatsu Y; Koinuma D; Shirouzu M; Miyazono K; Watabe T
    J Biol Chem; 2020 Sep; 295(36):12559-12572. PubMed ID: 32631954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression of melanoma is suppressed by targeting all transforming growth factor‑β isoforms with an Fc chimeric receptor.
    Kodama S; Podyma-Inoue KΑ; Uchihashi T; Kurioka K; Takahashi H; Sugauchi A; Takahashi K; Inubushi T; Kogo M; Tanaka S; Watabe T
    Oncol Rep; 2021 Sep; 46(3):. PubMed ID: 34296292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian transforming growth factor-beta (TGF-beta) receptors: in-vitro effects of follicle stimulating hormone, epidermal growth factor and TGF-beta on receptor expression in human preantral follicles.
    Roy SK; Kole AR
    Mol Hum Reprod; 1998 Mar; 4(3):207-14. PubMed ID: 9570266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel permissive role of epidermal growth factor in transforming growth factor beta (TGF-beta) signaling and growth suppression. Mediation by stabilization of TGF-beta receptor type II.
    Song K; Krebs TL; Danielpour D
    J Biol Chem; 2006 Mar; 281(12):7765-74. PubMed ID: 16428382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PDGF receptor-α promotes TGF-β signaling in hepatic stellate cells via transcriptional and posttranscriptional regulation of TGF-β receptors.
    Liu C; Li J; Xiang X; Guo L; Tu K; Liu Q; Shah VH; Kang N
    Am J Physiol Gastrointest Liver Physiol; 2014 Oct; 307(7):G749-59. PubMed ID: 25169976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-beta induces formation of a dithiothreitol-resistant type I/Type II receptor complex in live cells.
    Wells RG; Gilboa L; Sun Y; Liu X; Henis YI; Lodish HF
    J Biol Chem; 1999 Feb; 274(9):5716-22. PubMed ID: 10026191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential responsiveness to autocrine and exogenous transforming growth factor (TGF) beta1 in cells with nonfunctional TGF-beta receptor type III.
    Deng X; Bellis S; Yan Z; Friedman E
    Cell Growth Differ; 1999 Jan; 10(1):11-8. PubMed ID: 9950213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different domains regulate homomeric and heteromeric complex formation among type I and type II transforming growth factor-beta receptors.
    Rechtman MM; Nakaryakov A; Shapira KE; Ehrlich M; Henis YI
    J Biol Chem; 2009 Mar; 284(12):7843-52. PubMed ID: 19147499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of transforming growth factor-β signaling promotes collective cancer cell invasion through tumor-stromal crosstalk.
    Matise LA; Palmer TD; Ashby WJ; Nashabi A; Chytil A; Aakre M; Pickup MW; Gorska AE; Zijlstra A; Moses HL
    Breast Cancer Res; 2012 Jul; 14(4):R98. PubMed ID: 22748014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular and cytoplasmic domains of endoglin interact with the transforming growth factor-beta receptors I and II.
    Guerrero-Esteo M; Sanchez-Elsner T; Letamendia A; Bernabeu C
    J Biol Chem; 2002 Aug; 277(32):29197-209. PubMed ID: 12015308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pivotal role for the transmembrane domain in transforming growth factor-beta receptor activation.
    Zhu HJ; Sizeland AM
    J Biol Chem; 1999 Apr; 274(17):11773-81. PubMed ID: 10206994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The type II TGF-β receptor phosphorylates Tyr
    Yakymovych I; Yakymovych M; Hamidi A; Landström M; Heldin CH
    Sci Signal; 2022 Nov; 15(760):eabp9521. PubMed ID: 36378749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of expression of TGF-beta1, TbetaRI, and TbetaRII correlates with differentiation in human oral squamous cell carcinomas.
    Mincione G; Di Marcantonio MC; Artese L; Vianale G; Piccirelli A; Piccirilli M; Perrotti V; Rubini C; Piattelli A; Muraro R
    Int J Oncol; 2008 Feb; 32(2):323-31. PubMed ID: 18202754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Src family kinase inhibitors PP2 and PP1 block TGF-beta1-mediated cellular responses by direct and differential inhibition of type I and type II TGF-beta receptors.
    Ungefroren H; Sebens S; Groth S; Gieseler F; Fändrich F
    Curr Cancer Drug Targets; 2011 May; 11(4):524-35. PubMed ID: 21395548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor-beta (TGF-beta) type I and type II receptors are both required for TGF-beta-mediated extracellular matrix production in lung fibroblasts.
    Zhao Y
    Mol Cell Endocrinol; 1999 Apr; 150(1-2):91-7. PubMed ID: 10411303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-beta (TGF-beta1) activates TAK1 via TAB1-mediated autophosphorylation, independent of TGF-beta receptor kinase activity in mesangial cells.
    Kim SI; Kwak JH; Na HJ; Kim JK; Ding Y; Choi ME
    J Biol Chem; 2009 Aug; 284(33):22285-22296. PubMed ID: 19556242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding affinity of transforming growth factor-beta for its type II receptor is determined by the C-terminal region of the molecule.
    Qian SW; Burmester JK; Tsang ML; Weatherbee JA; Hinck AP; Ohlsen DJ; Sporn MB; Roberts AB
    J Biol Chem; 1996 Nov; 271(48):30656-62. PubMed ID: 8940041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signaling by chimeric erythropoietin-TGF-beta receptors: homodimerization of the cytoplasmic domain of the type I TGF-beta receptor and heterodimerization with the type II receptor are both required for intracellular signal transduction.
    Luo K; Lodish HF
    EMBO J; 1996 Sep; 15(17):4485-96. PubMed ID: 8887540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibulin-3 is a novel TGF-β pathway inhibitor in the breast cancer microenvironment.
    Tian H; Liu J; Chen J; Gatza ML; Blobe GC
    Oncogene; 2015 Nov; 34(45):5635-47. PubMed ID: 25823021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.